About Divakar
Divakar Gupta is a partner at Cooley LLP, specializing in capital markets, especially within the biopharmaceutical sector. He is admitted to practice regulation in Texas, California, and New York, with a lively status in all jurisdictions.
Gupta earned his law degree (J.D.) from Harvard Law School in 2000, graduating cum laude. Prior to that, he obtained a Bachelor of Science (B.S.) in Chemistry from Yale University in 1997, where he graduated magna cum laude and was elected to Phi Beta Kappa.
His areas of practice consist of representing public and personal rising growth companies and investment banking firms. Gupta's expertise encompasses public services of equity, high-yield debt, and convertible debt, as well as venture capital financings and mergers and acquisitions. He has meaningful experience advising on securities and general company matters throughout a number of industries, including life sciences, technology, healthcare, REITs, energy, and retail.
Gupta joined Cooley LLP as a companion within the business department's capital markets practice group in New York on March 10, 2014, after serving as a partner at Latham & Watkins LLP. His legal practice involves various levels, which includes negotiations and public offerings, even though particular facts regarding proceedings, appeals, litigation, or trials are not publicly disclosed.
In 2015, Gupta was acknowledged as a capital markets "Rising Star" by Law360 for his contributions to complicated offers in the lifestyles sciences and technological know-how sectors. He is actively involved within the legal network and keeps his professional institutions.
